Results 41 to 50 of about 270,728 (301)

Heart Failure Monitoring System Based on Wearable and Information Technologies [PDF]

open access: yes, 2007
In Europe, Cardiovascular Diseases (CVD) are the leading source of death, causing 45% of all deceases. Besides, Heart Failure, the paradigm of CVD, mainly affects people older than 65.
Arredondo Waldmeyer, Maria Teresa   +4 more
core   +2 more sources

Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. [PDF]

open access: yes, 2015
Apolipoprotein L1 gene (APOL1) G1 and G2 coding variants are strongly associated with chronic kidney disease (CKD) in African Americans (AAs). Here APOL1 association was tested with baseline estimated glomerular filtration rate (eGFR), urine albumin ...
Bild, Diane E   +14 more
core   +1 more source

Trends of cause-specific cardiovascular disease mortality in China, 2009-2019: a nationwide longitudinal study

open access: yesAnnals of Medicine
Background Cardiovascular disease (CVD) is the top cause of death in China. We aimed to identify trends in cause-specific CVD mortality in a rapidly developing country, thereby providing evidence for CVD prophylaxis.Materials and Methods Using raw data ...
Lu Wang   +7 more
doaj   +1 more source

Phenotype of higher post-load insulin response as a predictor of all-cause mortality and cardiovascular mortality in the Chinese non-diabetic population

open access: yesDiabetology & Metabolic Syndrome, 2022
Aim This study aimed to assess whether a higher insulin response increased the long-term risk of mortality in a non-diabetic population. Methods A total of 446 people with normal glucose tolerance (NGT) or impaired glucose tolerance (IGT) who ...
Xiaoxia Shen   +8 more
doaj   +1 more source

High cardiovascular disease mortality after penile squamous cell carcinomas diagnosis: Results from the United States SEER population, 2005-2016

open access: yesFrontiers in Oncology, 2022
BackgroundCancer survivorship care is an emerging and necessary component of oncology management. To explore cardiovascular disease (CVD)-specific mortality and prognostic factors among patients with penile squamous cell carcinomas (PSCC).
Zequan Xie   +7 more
doaj   +1 more source

Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals with Nonalcoholic Fatty Liver Disease [PDF]

open access: yes, 2014
Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the United States and is associated with an increased risk of cardiovascular disease (CVD) and cardiovascular (CV) mortality, independent of traditional ...
Chalasani, Naga, Corey, Kathleen E.
core   +1 more source

Renal outcomes and all‐cause death associated with sodium‐glucose co‐transporter‐2 inhibitors versus other glucose‐lowering drugs ( CVD‐REAL 3 Korea ) [PDF]

open access: yesDiabetes, Obesity and Metabolism, 2020
Abstract Aims To investigate the effectiveness of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors on the risk of progression to end‐stage renal disease (ESRD) and all‐cause mortality in a broad range of patients with type 2 diabetes (T2D) using a Korean nationwide cohort.
Eun Sil Koh   +8 more
openaire   +2 more sources

“Pipa” means early death: Obesity and cardiovascular disease (CVD) risks perception, knowledge and behavior among minority NYC cab drivers—A qualitative analysis [PDF]

open access: yesJournal of Clinical and Translational Science, 2017
OBJECTIVES/SPECIFIC AIMS: More than 2 out of 3 adults in the United States are overweight or obese. Obesity disproportionately affects minority populations. There is limited data on obesity and CVD risks among inner-city minority cab drivers in New York City (NYC).
Balavenkatesh Kanna   +8 more
openaire   +2 more sources

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. [PDF]

open access: yes, 2015
IgG anti-apolipoprotein A-1 (IgG anti-apoA-1) antibodies are present in patients with systemic lupus erythematosus (SLE) and may link inflammatory disease activity and the increased risk of developing atherosclerosis and cardiovascular disease (CVD) in ...
Alber, KF   +9 more
core   +1 more source

Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment

open access: yesPreventive Medicine Reports, 2017
Several randomized controlled trials have shown a benefit of high-dose intensive statin treatment in reducing risk of death and second cardiovascular disease (CVD) events in patients previously diagnosed with an acute coronary syndrome (ACS).
J. Rockberg   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy